Educational research & price index · Independent Janoshik & MZ Biolabs COA verification
Guide|3 CitationsGLP-1 & MetabolicFemale-friendly

Cagrilintide

Also known as: AM833, Long-Acting Amylin Analog, CagriSema Component

Dose Range
0.25–2.4 mgResearch range
0Typical research window: 0.25–2.4 mg3 mg

Studied in published research — not a medical recommendation. Primary protocol (Phase 2/3 Titration Protocol): 0.25 mg to 2.4 mg (escalating every 4 weeks), Once weekly.

Protocol at a Glance
How Often
Once weekly

Once weekly

A Typical Run
32–68 weeks

Research-reported range; the linked study used a different dose or units. Often researched alongside Semaglutide or Tirzepatide at 0.25mg–1.0mg/week to break weight-loss plateaus

How It's Taken
Vial

Subcutaneous injection

Evidence
Established

Human clinical trials or FDA-approved formulation exists

Half-Life & 72-Hour Clearance Shape
Not established

No verified human half-life on file for this compound

0h18h36h54h72h
On Your SyringeU-100 Insulin Syringe

A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.

5 mg vial · 2 mL water · 0.5 mL syringe
Concentration: 2.5 mg in every mL (25 mcg per unit)
0u10u20u30u40u50u
Low end: 0.25 mg10 units
High end: 2.4 mg96 units

All U-100: 100 units = 1 mL. 20 doses in the vial at the low end (2 doses at the high end).

Track the doses you run

Save Cagrilintide to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.

Verified Peptide Vial Suppliers · Sorted by Real $/mg•Checked Nov 11, 2026

Cagrilintide supplier & $/mg comparison.

Source:
Max $/mg:
Sort:
Ascension Peptides50% OFF AUTO-APPLIED
Batch COAs (Kovera Labs, MZ Biolabs) on product page
US Domestic Vial
50% Off First Order Link
$50.00 net$100.00
10mg vial, sold as “C-10”
$5.00/mg$10.00/mg retail
Ameano Peptides
Batch COA portal on store site
US Domestic Vial
List price (verified Oct 30)
$88.00
10mg vial
$8.80/mg
Direct Peptides
COA per store product page
US Domestic Vial
List price (last verified Nov 4, 2026; store now requires sign-in)
$109.00
10mg vial
$10.90/mg
Elite Research USA
Batch COA on product page
US Domestic Vial
List price
$115.00
10mg vial, sold as “ER-CA”
$11.50/mg
Peptyes
Horizon Analytical UPLC-MS COA, lot DPS-5349209 (99.32%); COA names Privilege Bio Labs (Peptyes says: its manufacturer)
US Domestic Vial
List price (verified Nov 11, 2026); code PEPTIDEPROTOCOLS takes 10% off at checkout
$138.00
10mg vial
$13.80/mg
Polaris Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$140.00
10mg vial
$14.00/mg
Bulletproof BioLabs
ILS Laboratories HPLC COA COA-2026-RUDPS1, lot BPB-2610-001
US Domestic Vial
Vendor-supplied list price (Nov 7, 2026; store requires login)
$72.00
5mg vial
$14.40/mg
Protide Health
Per-lot COA (Freedom Diagnostics, HPLC-MS) on product page
US Domestic Vial
List price
$155.00
10mg vial
$15.50/mg
Swift Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$164.99
10mg vial
$16.50/mg
BioLongevity Labs
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$170.00
5mg vial
$34.00/mg
Sorted strictly by calculated $/mg or 2026 COA score. Only research peptide vial suppliers are included in $/mg benchmarks.
Full Verified $/mg Index →

At a Glance · 2026 FDA / 503A / WADA / Evidence Profile

Phase 2/3 Clinical TrialsTier 2 — Human Phase 1/2 Clinical Data
Pharmacological Class
Long-Acting Acylated Amylin & Calcitonin Receptor Dual Agonist (DACRA)
Administration Route
Under-the-skin injection (Subcutaneous injection)
2026 FDA & 503A Status
Active Phase 2/3 human clinical trials in 2026; not yet FDA-approved for commercial prescription or 503A bulk pharmacy compounding. Sold strictly as an analytical laboratory reference standard.
WADA Sport Status
Prohibited at All Times (WADA S0 Unapproved Substances & S2.2 Peptide Hormones, Growth Factors & Mimetics)
Evidence Tier
Tier 2 — Human Phase 1/2 Clinical Data: Published human Phase 1/2 clinical studies, regional regulatory approval, or controlled human biomarker trials
What is a GLP-1 Agonist?

A molecule that mimics glucagon-like peptide-1 (GLP-1), a hormone that regulates blood sugar, slows gastric emptying, and reduces appetite. Semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) are GLP-1 agonists. These are peptides, but they are marketed and prescribed as pharmaceutical drugs.

EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. Cagrilintide is not FDA approved for human use (unless specified above). This information does not constitute medical advice.

Overview

Cagrilintide (AM833) is a long-acting, lipidated amylin analog developed by Novo Nordisk. Unlike GLP-1 receptor agonists that act via incretin pathways, Cagrilintide targets calcitonin and amylin receptors (CTR/AMYR) in the hindbrain (area postrema) to induce non-GLP-1 satiety and slow gastric emptying. In Phase 3 REDEFINE trials, it is combined with Semaglutide as CagriSema.

Mechanisms of Action

  • Dual agonist of amylin receptors (AMYR1-3) and calcitonin receptors (CTR)
  • Acts centrally on the area postrema and nucleus tractus solitarius to enhance meal-induced satiety
  • Synergistic weight reduction when stacked with GLP-1 or GIP/GLP-1 agonists without overlapping receptor desensitization
  • Half-life of ~7–8 days via C20 fatty diacid acylation (albumin binding)

Research Protocols

Summaries of published research. For educational purposes only.

Protocol NameSourceDoseFrequencyDurationRouteEvidenceLinkSave
Phase 2/3 Titration Protocol
reported protocol
0.25 mg to 2.4 mg (escalating every 4 weeks)Once weekly32–68 weeksSubcutaneous injectionclinical trial
Baseline & Mid-Cycle Biomarker Bloodwork Panel

Metabolic, Hepatic & Incretin Safety Biomarker Panel (Cagrilintide)

Quantify visceral fat mobilization, insulin resistance reversal, hepatic steatosis (MASH) clearance, and pancreatic/renal safety during metabolic protocols.

Draw fasted morning labs at Baseline (Day 0) and Mid-Cycle (Week 6–8)

HbA1c & Fasting Insulin (HOMA-IR)

Day 0 + Wk 6–8

Why track at baseline: Measures baseline hyperinsulinemia and 90-day glycemic load prior to incretin or lipolytic initiation.

Week 6–8 check: Track rapid drop in Fasting Insulin (often 30%–50% reduction by Week 6–8) and normalizing HbA1c.

ALT, AST & GGT Liver Enzymes

Day 0 + Wk 6–8

Why track at baseline: Dual/triple agonists (Retatrutide, Mazdutide, Pemvidutide) mobilize 65%–80% of intrahepatic triglycerides.

Week 6–8 check: Confirm progressive reduction in ALT/AST (<25 U/L) as hepatic steatosis clears.

ApoB, Triglycerides & Advanced Lipid Panel

Day 0 + Wk 6–8

Why track at baseline: Quantifies atherogenic particle burden and VLDL triglyceride export before weight loss.

Week 6–8 check: Expect 20%–40% triglyceride drop and significant ApoB improvement alongside visceral fat loss.

Serum Lipase, Amylase & eGFR / Cystatin C

Day 0 + Wk 6–8

Why track at baseline: Essential safety screen for subclinical pancreatic inflammation and hydration/renal filtration.

Week 6–8 check: Ensure Lipase stays within reference range and eGFR remains stable with adequate electrolyte hydration.

Test before and during your protocol: one baseline panel of 100+ Quest biomarkers covering the markers above, plus a mid-cycle retest. No doctor visit required.Code SPAMBASSADOR
Get baseline bloodwork at Superpower

Community Outcomes

Community Data Coming Soon

Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!

Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.

Important Warnings

  • •Currently in Phase 3 trials — not yet FDA approved
  • •Requires pH-appropriate reconstitution (check batch salt form before mixing in same syringe with GLP-1s)
  • •GI side effects (nausea, early fullness) common during titration
Sourcing, Diagnostic Bloodwork & Telehealth Pathways

Where to get Cagrilintide, baseline labs & clinician oversight.

Full Cagrilintide $/mg comparison →
50% OFF AUTO-APPLIED$5.00/mg net

Ascension Peptides (US Vials)

MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.

MZ Biolabs COA (Grade A)Claim 50% Off
Verified Vial SuppliersGrade A COA

SwissChems & Limitless Biotech

Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).

LABS & 503A CLINICS$199/yr Labs · Rx Consult

Superpower Labs & 503A Telehealth

Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.

Code:SPAMBASSADOR

Where to buy Cagrilintide: best verified price

Prices checked Nov 11, 2026 · sorted by $/mg · RUO

  1. 1. Ascension Peptides — $5.00/mg (10mg vial, sold as “C-10”, $50.00)
  2. 2. Ameano Peptides — $8.80/mg (10mg vial, $88.00)
  3. 3. Direct Peptides — $10.90/mg (10mg vial, $109.00)

Where is the cheapest place to buy Cagrilintide?

As of Nov 11, 2026, the lowest verified US domestic single-vial price we found is Ascension Peptides at $5.00/mg (10mg vial, sold as “C-10”, $50.00 after the 50% new-customer partner-link discount). We compared 10 US suppliers with live, checked prices.

How much does Cagrilintide cost per mg?

Verified US domestic prices currently range from $5.00/mg to $34.00/mg depending on supplier and vial size. Larger vials usually lower the $/mg.

How are these prices verified?

Each price is read from the supplier's own product page or store data and divided by the vial's mg. Suppliers we could not verify are left out rather than estimated. Tables sort strictly by $/mg, never by partner status. Prices are re-checked weekly on our price index.

Is Cagrilintide approved for human use?

Products from these suppliers are sold for laboratory research use only (RUO). This page is an educational price reference, not medical advice.

All compounds $/mgWeekly $/mg price indexReconstitution calculatorFree cheat sheet

FREE 1-PAGE PDF CHEAT SHEET

Peptide Reconstitution & U-100 Syringe Cheat Sheet

Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.

Unsubscribe anytime.Direct PDF Download

Related Peptides

Vendor vs vendor: price per mg

Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.

Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →

Common questions

How many peptides are in the database?

100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.

Where can I compare peptide prices?

Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.